Frontiers in Neuroscience,
Journal Year:
2020,
Volume and Issue:
14
Published: Oct. 30, 2020
Alzheimer's
disease
(AD)
is
a
multifactorial,
age-related
neurological
characterized
by
complex
pathophysiological
dynamics
taking
place
at
multiple
biological
levels,
including
molecular,
genetic,
epigenetic,
cellular
and
large-scale
brain
networks.
These
alterations
account
for
mechanisms
such
as
protein
accumulation,
neuroinflammatory/neuro-immune
processes,
synaptic
dysfunction,
neurodegeneration
that
eventually
lead
to
cognitive
behavioral
decline.
Alterations
in
microRNA
(miRNA)
signaling
have
been
implicated
the
epigenetics
molecular
genetics
of
all
neurobiological
processes
associated
with
AD
pathophysiology.
changes
encompass
altered
miRNA
abundance,
speciation
complexity
anatomical
regions
CNS
targeted
disease,
modified
expression
patterns
tissues,
systemic
circulation,
extracellular
fluid
(ECF)
cerebrospinal
(CSF).
miRNAs
investigated
candidate
biomarkers
diagnosis,
prediction,
prognosis
therapeutic
purposes
because
their
involvement
pathways
both
health
disease.
In
this
review
we
will:
(i)
highlight
significantly
heterogeneous
nature
tissues
biofluids;
(ii)
address
how
information
may
be
extracted
from
these
data
used
diagnostic,
prognostic
and/or
screening
tools
across
entire
continuum
AD,
preclinical
stage,
through
prodromal,
i.e.,
mild
impairment
(MCI)
phase
way
clinically
overt
dementia;
(iii)
consider
specific
could
categorized
using
reporters
span
initiation
progression.
Molecular Therapy — Nucleic Acids,
Journal Year:
2019,
Volume and Issue:
19, P. 413 - 420
Published: Dec. 6, 2019
Circular
RNAs
(circRNAs)
are
group
of
noncoding
derived
from
back-splicing
events.
Accumulating
evidence
certifies
the
critical
roles
circRNAs
in
human
tumorigenesis.
However,
role
and
biogenesis
cervical
cancer
still
unclear.
Here,
a
novel
identified
circRNA,
circSLC26A4,
was
found
to
be
upregulated
tissue
cells.
Clinically,
high
expression
circSLC26A4
related
poor
survival
patients.
Functionally,
cellular
experiments
indicated
that
knockdown
repressed
proliferation,
invasion,
tumor
growth
vitro
vivo.
Furthermore,
acted
as
sponge
miR-1287-5p;
moreover,
miR-1287-5p
targeted
3′
UTR
HOXA7
mRNA.
Mechanistically,
RNA
binding
protein
(RBP)
quaking
(QKI)
interact
with
QKI
response
elements
(QREs)
SLC26A4
gene
introns,
thereby
promoting
biogenesis.
In
conclusion,
these
findings
demonstrate
facilitates
progression
through
QKI/circSLC26A4/miR-1287-5p/HOXA7
axis,
which
might
bring
therapeutic
strategies
for
cancer.
Journal of Experimental & Clinical Cancer Research,
Journal Year:
2020,
Volume and Issue:
39(1)
Published: Sept. 7, 2020
Abstract
Background
Glioma
is
the
most
common
and
lethal
primary
brain
tumor
in
adults,
angiogenesis
one
of
key
factors
contributing
to
its
proliferation,
aggressiveness,
malignant
transformation.
However,
discovery
novel
oncogenes
study
molecular
regulating
mechanism
based
on
circular
RNAs
(circRNAs)
may
provide
a
promising
treatment
target
glioma.
Methods
Bioinformatics
analysis,
qPCR,
western
blotting,
immunohistochemistry
were
used
detect
expression
levels
ISL2
,
miR-342–3p,
circRNA
ARF1
(cARF1),
U2AF2
VEGFA
.
Patient-derived
glioma
stem
cells
(GSCs)
established
for
experiments.
Lentiviral-based
infection
was
regulate
these
molecules
GSCs.
The
MTS,
EDU,
Transwell,
tube
formation
assays
invasion,
human
microvessel
endothelial
(hBMECs).
RNA-binding
protein
immunoprecipitation,
RNA
pull-down,
dual-luciferase
reporter,
chromatin
immunoprecipitation
direct
regulation
mechanisms
among
molecules.
Results
We
first
identified
transcription
factor
related
neural
development.
overexpressed
correlated
with
poor
patient
survival.
transcriptionally
regulated
GSCs
promoted
hBMECs
via
-mediated
ERK
signaling.
Regarding
action,
cARF1
upregulated
miR-342–3p
sponging.
Furthermore,
bound
stability
cARF1,
while
induced
which
formed
feedback
loop
also
showed
that
both
had
an
oncogenic
effect,
glioma,
Conclusions
Our
This
angiogenesis,
could
effective
biomarker
diagnosis
prognostic
evaluation,
as
well
possibly
being
targeted
therapy.
Cell Reports,
Journal Year:
2021,
Volume and Issue:
36(4), P. 109439 - 109439
Published: July 1, 2021
Highlights•The
rate
of
back-splicing
for
a
gene
declines
with
its
degree
splicing•The
abundance
in
species
effective
population
size•Mammalian
circRNAs
are
overall
evolutionarily
non-conserved•More
than
97%
the
observed
circRNA
production
is
deleteriousSummaryUbiquitous
eukaryotes,
circular
RNAs
(circRNAs)
comprise
large
class
mostly
non-coding
produced
by
back-splicing.
Although
some
have
demonstrated
biochemical
activities,
whether
most
functional
unknown.
Here,
we
test
hypothesis
that
primarily
results
from
splicing
error
and
so
deleterious
instead
beneficial.
In
support
hypothesis,
our
analysis
RNA
sequencing
data
11
shared
tissues
humans,
macaques,
mice
finds
(1)
much
rarer
linear-splicing,
(2)
diminishes
amount,
(3)
prevalence
size,
(4)
unconserved.
We
estimate
more
deleterious.
identify
small
number
candidates,
genome-wide
trend
strongly
suggests
largely
non-functional
products
errors.Graphical
abstract
Frontiers in Neuroscience,
Journal Year:
2020,
Volume and Issue:
14
Published: Oct. 30, 2020
Alzheimer's
disease
(AD)
is
a
multifactorial,
age-related
neurological
characterized
by
complex
pathophysiological
dynamics
taking
place
at
multiple
biological
levels,
including
molecular,
genetic,
epigenetic,
cellular
and
large-scale
brain
networks.
These
alterations
account
for
mechanisms
such
as
protein
accumulation,
neuroinflammatory/neuro-immune
processes,
synaptic
dysfunction,
neurodegeneration
that
eventually
lead
to
cognitive
behavioral
decline.
Alterations
in
microRNA
(miRNA)
signaling
have
been
implicated
the
epigenetics
molecular
genetics
of
all
neurobiological
processes
associated
with
AD
pathophysiology.
changes
encompass
altered
miRNA
abundance,
speciation
complexity
anatomical
regions
CNS
targeted
disease,
modified
expression
patterns
tissues,
systemic
circulation,
extracellular
fluid
(ECF)
cerebrospinal
(CSF).
miRNAs
investigated
candidate
biomarkers
diagnosis,
prediction,
prognosis
therapeutic
purposes
because
their
involvement
pathways
both
health
disease.
In
this
review
we
will:
(i)
highlight
significantly
heterogeneous
nature
tissues
biofluids;
(ii)
address
how
information
may
be
extracted
from
these
data
used
diagnostic,
prognostic
and/or
screening
tools
across
entire
continuum
AD,
preclinical
stage,
through
prodromal,
i.e.,
mild
impairment
(MCI)
phase
way
clinically
overt
dementia;
(iii)
consider
specific
could
categorized
using
reporters
span
initiation
progression.